| http://dbpedia.org/ontology/abstract
|
The number of new psychiatric drugs, and e … The number of new psychiatric drugs, and especially antidepressants on the market in Japan, is significantly less than Western countries. One of the biggest barriers to antidepressants coming to the market is that the medical insurance system in Japan is national, and the authorities are keen to contain a potentially explosive market for drugs like antidepressants that could be used or abused by persons in various forms of distress. Although large epidemiological studies have not been done in Japan, it is thought that up to 6 million Japanese suffer from depression, with a lifetime prevalence of 13 to 17.3%, which is similar to that seen in Western countries.similar to that seen in Western countries.
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654524/ +
, http://www.ncnp.go.jp/english/index.html +
, http://www.japanpsychiatrist.com/DrugDev.html +
, http://www.mhlw.go.jp/english/index.html +
, http://www.igakuken.or.jp/english/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
13135951
|
| http://dbpedia.org/ontology/wikiPageLength
|
11329
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1120147108
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Vortioxetine +
, http://dbpedia.org/resource/Antidepressants +
, http://dbpedia.org/resource/Category:Drugs_in_Japan +
, http://dbpedia.org/resource/Sertraline +
, http://dbpedia.org/resource/Paroxetine +
, http://dbpedia.org/resource/Western_world +
, http://dbpedia.org/resource/Pharmacologic +
, http://dbpedia.org/resource/Takeda_Pharmaceutical_Company +
, http://dbpedia.org/resource/Major_depressive_disorder +
, http://dbpedia.org/resource/Trazodone +
, http://dbpedia.org/resource/Fluvoxamine +
, http://dbpedia.org/resource/Enantiomer +
, http://dbpedia.org/resource/Meiji_Seika +
, http://dbpedia.org/resource/Mirtazapine +
, http://dbpedia.org/resource/Category:Antidepressants +
, http://dbpedia.org/resource/Tricyclic_antidepressants +
, http://dbpedia.org/resource/Tricyclic_antidepressant +
, http://dbpedia.org/resource/Fluoxetine +
, http://dbpedia.org/resource/Ministry_of_Health%2C_Labour_and_Welfare +
, http://dbpedia.org/resource/Japan +
, http://dbpedia.org/resource/Lundbeck +
, http://dbpedia.org/resource/Psychiatric_medication +
, http://dbpedia.org/resource/Social_welfare_in_Japan +
, http://dbpedia.org/resource/Selective_serotonin_reuptake_inhibitor +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Duloxetine +
, http://dbpedia.org/resource/Bupropion +
, http://dbpedia.org/resource/Epidemiology +
, http://dbpedia.org/resource/Organon_International +
, http://dbpedia.org/resource/Mood_disorders +
, http://dbpedia.org/resource/Escitalopram +
, http://dbpedia.org/resource/SNRI +
, http://dbpedia.org/resource/Citalopram +
, http://dbpedia.org/resource/Selective_serotonin_reuptake_inhibitors +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Antidepressants +
, http://dbpedia.org/resource/Category:Drugs_in_Japan +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Antidepressants_in_Japan?oldid=1120147108&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Antidepressants_in_Japan +
|
| owl:sameAs |
http://dbpedia.org/resource/Antidepressants_in_Japan +
, http://yago-knowledge.org/resource/Antidepressants_in_Japan +
, https://global.dbpedia.org/id/4Qz1w +
, http://rdf.freebase.com/ns/m.02z844z +
, http://www.wikidata.org/entity/Q4774671 +
|
| rdf:type |
http://dbpedia.org/class/yago/Antidepressant102718811 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Drug103247620 +
, http://dbpedia.org/class/yago/WikicatDrugsInJapan +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://dbpedia.org/class/yago/WikicatAntidepressants +
, http://dbpedia.org/class/yago/Medicine103740161 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/Substance100020090 +
|
| rdfs:comment |
The number of new psychiatric drugs, and e … The number of new psychiatric drugs, and especially antidepressants on the market in Japan, is significantly less than Western countries. One of the biggest barriers to antidepressants coming to the market is that the medical insurance system in Japan is national, and the authorities are keen to contain a potentially explosive market for drugs like antidepressants that could be used or abused by persons in various forms of distress.d by persons in various forms of distress.
|
| rdfs:label |
Antidepressants in Japan
|
